Our vials feature tamper-evident sealed closures and clear research-use labeling, ensuring every unit you receive is exactly what it should be a reliable, research-grade reconstitution solution
Here's what the research literature describes about its structure and the pathways it's studied in
Both peptides are generally considered well-tolerated in preclinical studies, but mild injection-site reactions, nausea, dizziness, or rare allergic responses have been reported
Common Topical Application Patterns Use case Facial anti-aging (community use) Concentration 1-2% Frequency Once or twice daily Cycle length 8-12 weeks Use case Scalp / hair-research interest Concentration 1-3% Frequency Daily Cycle length 12+ weeks ongoing Use case Compounded post-procedure Concentration 1-2% Frequency Per clinician guidance Cycle length Per clinician guidance Topical concentrations are typically expressed as percent weight
Real follow-up: the 3 month cycle is monitored
DSIP promotes sleep in a species-specific manner, with varying effects on different types of sleep across species